Anish Bhatnagar (CIK 1614821) reported 22 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-18). Recent activity: Sell SLNO (583,656 shares), Buy SLNO (114,200 shares), Sell SLNO (7,620 shares), Sell SLNO (100,000 shares), Sell SLNO (14,183 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 583,656 | $0 |
| 2026-01-23 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Buy | 114,200 | $0 |
| 2025-12-17 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 7,620 | $380,619 |
| 2025-12-17 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 100,000 | $0 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 14,183 | $935,653 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 23,095 | $1.5M |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 41,989 | $2.8M |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 55,234 | $3.8M |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 31,980 | $2.2M |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 3,291 | $232,772 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 4,782 | $343,061 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 732 | $53,172 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Buy | 26,606 | $638,544 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Buy | 16,666 | $417,483 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Buy | 105,000 | $3.5M |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Buy | 32,193 | $164,184 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Buy | 62,291 | $150,121 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Buy | 281,053 | $1.5M |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 106,471 | $7.0M |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 209,689 | $13.9M |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 8,423 | $567,458 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 199,226 | $13.8M |
Source: SEC Form 4 filings · as of 2026-05-18